Hyperthermia for Targeting Cancer and Cancer Stem Cells: Insights from Novel Cellular and Clinical Approaches
Stem Cell Reviews and Reports · 2024
DOI: 10.1007/s12015-024-10736-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cell Reviews and Reports, 2024. Verfasst von David M Smadja. Beteiligte Einrichtung: Paris Cité University, INSERM, Innovative Therapies in Hemostasis, Paris, F-75006, France. david.smadja@me.com. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Neoplasms, Hyperthermia, Induced. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
The Cellular Heat Shock Response and in particular heat shock protein activation are vital stress reactions observed in both healthy and cancer cells. Hyperthermia (HT) has been proposed for several years as an advancing non-invasive cancer therapy. It selectively targets cancer cells through mechanisms influenced by temperature and temperature variations. This article delves into the impact of HT on cancer cells, especially cancer stem cells (CSCs), essential contributors to cancer recurrence and metastasis. HT has shown promise in eliminating CSCs, sensitizing them to conventional treatments and modulating the tumor microenvironment. The exploration extends to mesenchymal stem cells (MSCs), which exhibit both pro-tumorigenic and anti-tumorigenic effects. HT's potential in recruiting therapeutic MSCs for targeted delivery of antitumoral agents is also discussed. Furthermore, the article introduces Brain Thermodynamics-guided Hyperthermia (BTGH) technology, a breakthrough in temperature control and modulation of heat transfer under different conditions. This non-invasive method leverages the brain-eyelid thermal tunnel (BTT) to monitor and regulate internal brain temperature. BTGH technology, with its precision and noninvasive continuous monitoring capabilities, is under clinical investigation for applications in neurological disorders and cancer. The innovative three-phase approach involves whole-body HT, targeted brain HT, and organ-specific HT. In conclusion, the exploration of localized or whole-body HT offers promising avenues for cancer, psychiatric and neurological diseases. The ongoing clinical investigations and potential applications underscore the significance of understanding and harnessing heat's responses to enhance human health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Paris Cité University, INSERM, Innovative Therapies in Hemostasis, Paris, F-75006, France. david.smadja@me.com.
- Hematology Department, AP-HP, Georges Pompidou European Hospital, 20 rue Leblanc, Paris, F-75015, France. david.smadja@me.com.
ORCID-Profile: David M Smadja
Zitieren
APA
Smadja, D. M. (2024). Hyperthermia for Targeting Cancer and Cancer Stem Cells: Insights from Novel Cellular and Clinical Approaches. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-024-10736-0
Vancouver
Smadja DM. Hyperthermia for Targeting Cancer and Cancer Stem Cells: Insights from Novel Cellular and Clinical Approaches. Stem Cell Reviews and Reports. 2024. doi:10.1007/s12015-024-10736-0
BibTeX
@article{Smadja2024,
author = {Smadja, David M},
title = {Hyperthermia for Targeting Cancer and Cancer Stem Cells: Insights from Novel Cellular and Clinical Approaches},
journal = {Stem Cell Reviews and Reports},
year = {2024},
doi = {10.1007/s12015-024-10736-0}
}
EUVIMED